Clinical trials
Parkinson Disease, Idiopathic clinical trials
Below are recruiting parkinson disease, idiopathic clinical trials, each written for real people, not researchers. We’re tracking 210 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07138560RecruitingPhase 4
Study of IPX-203 for Parkinson's disease (BOOST-PD)
This study tests a new formulation of carbidopa-levodopa (IPX-203) to see how well it works for people with Parkinson's disease. It uses a wearable device to measure movement and aims to improve “off” time, when symptoms return between doses.
Cleveland, OhioAges 40 years+ - NCT07299448Recruiting
Parkinson's and swallowing: what drives difficulty?
This study looks at why some people with Parkinson's have trouble swallowing (dysphagia) and how the brain adapts. It aims to understand the condition better, which could lead to better treatments.
Düsseldorf, North Rhine-WestphaliaAges 18 years+ - NCT07302386Recruiting
Exercise management in Parkinson's disease
This study tests an exercise program you can do from home using video calls. It aims to improve your walking and balance, and help you manage Parkinson's symptoms.
Maltepe, IstanbulAges 45–80 - NCT07322939Recruiting
Exercise with visual feedback for Parkinson's
This trial tests whether adding visual feedback to exercise can help people with mild to moderate Parkinson's disease improve their movement and balance. It is designed for people who are only taking oral Parkinson's medications.
Gaziantep, ŞahinbeyAges 18–85 - NCT07351032Recruiting
Learning walking movements in Parkinson's disease
This study looks at how people with Parkinson's learn and transfer walking movements from one task to another. You will walk on a special treadmill to help researchers understand how your brain adapts, which could lead to better rehab strategies.
Montreal, QuebecAges 50 years+ - NCT07381907Recruiting
Brain stimulation combined with Nordic walking for Parkinson's
This study combines a mild electrical brain stimulation (tDCS) with Nordic walking (walking with poles) to see if it helps improve walking and balance in people with Parkinson's disease. The treatment lasts 4 weeks and may be an option if you have a slow walking pace and no implanted brain devices.
Belém, ParáAges 50–75 - NCT07524400Recruiting
Exercise Plus Brain Stimulation for Parkinson's Disease
This study tests whether combining physical exercise with transcranial direct current stimulation (a non-invasive electrical stimulation of the brain) can improve movement and symptoms in people with Parkinson's disease. The goal is to see if this combination works better than exercise alone.
Fuenlabrada, MadridAges Any age - NCT07536542Recruiting
Dual-Task Training for Hand and Arm Function in Parkinson's
This study tests whether doing hand and arm exercises while performing a second task (like counting or listening) can improve movement and strength in people with Parkinson's disease. The goal is to help you move more smoothly and regain function in your hands and arms.
AnkaraAges 40–65 - NCT07585409Recruiting
Physical Activity for Parkinson's Disease Patients
This study tests whether physical activity (like exercise or movement) can help people with Parkinson's disease feel better and move more easily. Researchers want to understand how activity affects Parkinson's symptoms and quality of life.
StockholmAges 18 years+ - NCT07618728Recruiting
Community Exercise Program for Parkinson's Disease
This study tests whether a group exercise program designed for Parkinson's disease patients can be safely and practically run in a community setting. The program combines different types of movement and exercise to help improve function and quality of life.
Alcorcón, MadridAges 18 years+ - NCT06999330Enrolling by invitation
TMS for anxiety in Parkinson's disease
This study tests whether transcranial magnetic stimulation (TMS), a non-invasive brain treatment, can help reduce anxiety in people with Parkinson's disease. You may qualify if you have both Parkinson's and significant anxiety symptoms.
Saint Paul, MinnesotaAges 40–90 - NCT06885138Enrolling by invitation
Testing brain stimulation for depression in Parkinson's disease
This trial tests if a gentle brain stimulation technique called tDCS can improve depression symptoms in people with Parkinson's disease. You'll receive either real or placebo stimulation over several sessions to see if it helps your mood.
MilanAges 35–75 - NCT06823921Enrolling by invitation
Exercise and thinking in Parkinson's disease
This study tests whether high-intensity interval training (HIIT) can improve thinking skills in people with Parkinson's. If you are willing to exercise in a group, this trial might help you understand the benefits of exercise.
New Haven, ConnecticutAges 40 years+ - NCT06819020Enrolling by invitation
Adaptive deep brain stimulation for freezing of gait in Parkinson's
This trial tests an adaptive deep brain stimulation (DBS) system designed to improve freezing of gait in Parkinson’s disease. It is for people who still have trouble walking despite medications and are already planning to have DBS surgery.
San Francisco, CaliforniaAges 21–75 - NCT05504902Enrolling by invitation
Device training for advanced Parkinson’s using touch feedback
This study tests whether coordinated touch (vibrotactile) training can improve symptoms in people with Parkinson’s. You may be asked to use a special device and attend virtual check-ins, with some visits requiring stopping Parkinson’s meds for short periods.
Stanford, CaliforniaAges 18 years+ - NCT05166655Enrolling by invitation
Recording brain signals during deep brain stimulation for Parkinson’s
This study uses special recordings during deep brain stimulation surgery to better understand how movement gets easier in Parkinson’s disease. It may help researchers improve how this therapy is used for advanced symptoms.
Los Angeles, CaliforniaAges 18 years+ - NCT07774312Recruiting
Comparing tTIS treatment intervals to standard care for Parkinson's
This study compares different schedules of a non-invasive brain stimulation treatment (called tTIS) to standard medication for Parkinson's disease. It aims to find the best timing for tTIS to improve motor symptoms.
Shanghai, Shanghai MunicipalityAges 50–85 - NCT07513441RecruitingPhase 1
Testing Lu AF28996 for Parkinson's disease motor fluctuations
This early-stage trial tests a new medication called Lu AF28996 in Chinese patients with Parkinson's disease who experience predictable on-off episodes (times when medication works well versus poorly). The study aims to see if this drug can help reduce those difficult off periods.
Beijing, Beijing MunicipalityAges 35–85 - NCT07174310RecruitingPhase 3
Prasinezumab for early Parkinson's disease
This study tests a new medication called prasinezumab, given through a vein (IV), to see if it can slow the progression of early-stage Parkinson's disease. It is for people who are on only one Parkinson's medication and have not yet developed motor complications.
Birmingham, AlabamaAges 50–85 - NCT06742450Recruiting
Comparing two ways to stimulate the brain for Parkinson's
This trial compares two methods of deep brain stimulation (constant current vs constant voltage) for people with Parkinson's who already have the device placed but haven't turned it on yet. The goal is to see which method works better.
BeijingAges 18–75 - NCT06701955Recruiting
Reliability of a Fluctuation Scale in Parkinson's
This study tests how consistently a new scale measures 'on-off' fluctuations in Parkinson's disease. If you experience motor fluctuations (times when your symptoms change) and are on stable medication, you may help validate this tool.
GrenobleAges 30–75 - NCT07730073Recruiting
LSVT-LOUD therapy for voice and speech in Parkinson's disease
This study tests whether LSVT-LOUD, a speech therapy program, can improve voice, speech, and quality of life in people with Parkinson's disease who have voice or speech problems. Participants must be native Turkish speakers, aged 40-80, with mild to moderate Parkinson's.
Kâğıthane, IstanbulAges 40–80 - NCT04799470Recruiting
Testing new brain-stimulation patterns for Parkinson’s with DBS
This study tests whether different deep brain stimulation settings can improve symptoms in people with Parkinson’s who already have an implanted DBS system in the subthalamic nucleus (STN). To join, you must already have the specific Medtronic device and show good brain signal and symptom response after surgery.
Omaha, NebraskaAges 19–80 - NCT03025334Recruiting
Brain stimulation study for thinking changes in Parkinson’s
This study tests whether a non-invasive brain stimulation approach (tDCS) can improve thinking and memory in people with Parkinson’s disease. You may be invited because your Parkinson’s is typical and your memory testing shows you do not have dementia.
Winnipeg, ManitobaAges 40 years+
Hear when a new Parkinson Disease, Idiopathic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for parkinson disease, idiopathic?
- Yes. Clin2 currently lists 210 recruiting parkinson disease, idiopathic studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a parkinson disease, idiopathic trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a parkinson disease, idiopathic trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.